introduce human herpesviru hh recon potent signifies pathogen hemopoiet stem cell transplant hst recipe differ clinic manifest describe include fever skin rash bone marrow suppress except mater method retrospect review group adult allowed hst conduct serum sample taken examine present specify antihhv igm img antibody transplant quantity realtime per use determine viral load plasma day posttranspl result dna detect develop unknown origin graftversushost disease feature three individual die detect viremia not two show single post result later time infect thu confirm graft concur high frequency poland investing monitor reactive import improv outcome patient 